Scotts Miracle-Gro

Scotts Miracle-Gro Co. engages in the manufacturing, marketing, and sale of products for lawn and garden care and indoor and hydroponic gardening. Its products and services include lawn care, gardening and landscape, hydroponic hardware and growing environments, lighting, controls, and marketing agreement. It operates through the following segments: U.S. Consumer, Hawthorne, and Other. The U.S. Consumer and Other segments manufacture and market branded consumer lawn and garden products. The U.S. Consumer segment consists of consumer lawn and garden business in the United States. The Hawthorne segment manufactures, markets, and distributes lighting, nutrients, growing media, growing environments, and hardware products for indoor and hydroponic gardening in North America. The company was founded by Orlando McLean Scott in 1868 and is headquartered in Marysville, OH.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Scotts Miracle-Gro exceeds Q1 sales goal, eyes cannabis growth

Scotts Miracle-Gro (SMG) reported strong Q1 performance, exceeding sales goals and achieving profitability milestones.
Despite challenges in the Hawthorne segment, the company remains optimistic about growth opportunities in the cannabis sector.
Commitment to disciplined growth strategies, pricing strength, and leveraging free cash flow for debt repayment and potential reinvestment.
Focus on consumer engagement, market recovery, and maintaining liquidity to drive future success.

Scotts Miracle-Gro reports strong Q2 performance amidst industry challenges

Scotts Miracle-Gro (SMG) reported strong Q2 performance in the US Consumer business, with cost reductions and efficiency gains contributing to improved free cash flow.
While facing challenges in the Hawthorne segment, the company remains focused on reaching breakeven and aligning with the cannabis market's realities for improved performance.
Opportunities lie in positive industry developments, potential pricing adjustments, strategic partnerships in the cannabis market, and value creation initiatives.
Despite margin hindrances, Scotts Miracle-Gro (SMG) is optimistic about the season's progress and committed to growth strategies and profitability through innovation and partnerships.

Scotts Miracle-Gro faces challenges but eyes growth opportunities in 2024

Scotts Miracle-Gro faced challenges in meeting its targets but saw growth in consumer retail sales, with a focus on debt reduction and maintaining dividend payments.
The company is on track with its debt reduction plan, aiming for $1 billion over 2 years, and is exploring opportunities for margin accretion and partnerships for future growth.
Despite short-term financial challenges, Scotts Miracle-Gro is implementing cost-saving measures, focusing on broadening retailer relationships, and anticipating a return to $600 million EBITDA next year.
The Hawthorne business is stabilizing, aiming for profitability, exploring partnerships, and considering strategic actions to address industry challenges, while maintaining a commitment to debt reduction.

Scotts Miracle-Gro reports fiscal '23 improvements, eyes growth in '24

Scotts Miracle-Gro's fiscal '23 performance showcased financial discipline and operational improvements despite sales challenges, setting the stage for growth in fiscal '24.
The company's focus on core consumer, marketing, innovation, and strategic solutions positions it well to capitalize on opportunities for revenue growth and margin enhancement.
While facing challenges such as sales declines and margin pressures, Scotts Miracle-Gro's strategic outlook for fiscal '24 emphasizes growth, profitability, and operational efficiency.
By addressing concerns, leveraging data analytics, and enhancing marketing efforts, Scotts Miracle-Gro aims to drive performance and shareholder value in the upcoming year.

Scotts Miracle-Gro reports strong Q1 results, focuses on profitability

Scotts Miracle-Gro's Q1 performance reflects positive growth and margin improvement strategies.
The company is focused on profitability, leveraging strengths in North America and retail partnerships.
Challenges include managing leverage, transitioning Hawthorne to profitability, and SG&A adjustments.
Opportunities lie in volume growth, partnerships, and sustainable reinvestment for future growth.

Scotts Miracle-Gro surpasses financial targets and navigates industry challenges

Scotts Miracle-Gro delivered strong financial performance, exceeding targets and showcasing growth in consumer business. The focus on proprietary brands, partnerships, and cost optimization reflects a commitment to long-term success.
Challenges include pending deals, achieving profitability in Hawthorne, and navigating the evolving cannabis industry landscape. Opportunities in advertising, strategic partnerships, and cost optimization pave the way for future growth.
Overall, Scotts Miracle-Gro's Q2 earnings call highlighted solid performance, strategic initiatives, and a positive outlook for future sales growth. Management's focus on financial metrics, consumer engagement, and profitability sets a strong foundation for continued success.

Scotts Miracle-Gro reports strong Q3 performance and strategic growth focus

Scotts Miracle-Gro delivered a robust performance in Q3 2024, showcasing growth in net sales, profitability, and market share across its key divisions, driven by strategic initiatives and operational efficiencies.
While facing challenges related to increased SG&A expenses and market dynamics, the company's focus on debt reduction, margin improvement, and financial discipline positions it well for long-term success and sustainable growth.
With opportunities to capitalize on its strong market position, drive innovation, and optimize pricing strategies, Scotts Miracle-Gro is poised to navigate challenges and leverage growth prospects for enhanced shareholder value.

Scotts Miracle-Gro reports strong fiscal '24 performance and outlines growth plans for '25

Scotts Miracle-Gro's fiscal '24 showcased resilience and strategic progress, with a focus on cost-cutting, growth, and operational efficiency. The company is poised for sustained growth through brand investments and market strategies.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

GrowGeneration Corp

Hydrofarm Holdings Group

The US cannabis industry continues to expand, with sales projected to reach $41 billion by 2025, according to recent data. Ancillary cannabis companies, which provide essential products and services to growers and retailers, remain key players in this growth. These businesses benefit from industry expansion without directly handling the plant, reducing regulatory risks. Recent headlines highlight ongoing federal legalization discussions, signaling potential reforms to drive future demand. This week offers investors a prime opportunity to monitor top ancillary cannabis stocks as the market evolves.

Top Ancillary Cannabis Stocks to Watch Before 2025

The cannabis industry continues to grow and shows why people should be finding ways to invest. Now marijuana stocks for some time have been one of the tougher sectors to pull consistent profits from. There is a lack of continuous momentum and when there is it is often due to politics on cannabis reform. Other factors that help the sector build better momentum is when companies report strong earnings. When people can see that a company is thriving it entices them to invest looking further into marijuana stocks.

Top Marijuana Stocks For Better Market Action

The rise in Q4 sales is due to higher sales in SMG's U.S. Consumer segment.

Scotts Miracle-Gro's Q4 Earnings Miss Estimates, Sales Beat

As the cannabis market faces recent fluctuations, ancillary cannabis stocks present a unique opportunity for investors. Ancillary companies, which supply essential tools and services to growers and retailers, often show resilience during market downturns. The US cannabis industry continues its growth trajectory, valued at over $13 billion in 2023, with projections suggesting it will reach $40 billion by 2030. However, Amendment 3's failure in Florida has recently sparked a pullback. This setback has stalled expansion in one of the country's largest potential cannabis markets. Despite this, federal legalization talks persist, with recent headlines hinting at possible reform that could boost investor confidence.

Top Picks for Ancillary Cannabis Stocks During the Marijuana Market Downturn

Start Time: 09:00 January 1, 0000 10:32 AM ET The Scotts Miracle-Gro Company (NYSE:SMG ) Q4 2024 Earnings Call November 06, 2024, 09:00 AM ET Company Participants Jim Hagedorn - Chairman, President and CEO Matt Garth - EVP, CFO and CAO Nate Baxter - EVP and COO Chris Hagedorn - EVP and Division President, Hawthorne Gardening Company Aimee DeLuca - SVP, IR Conference Call Participants Jon Andersen - William Blair Joe Altobello - Raymond James William Carter - Stifel Peter Grom - UBS Chris Carey - Wells Fargo Securities Eric Bouchard - Cleveland Research William Reuter - Bank of America Carla Casella - JPMorgan Aimee DeLuca Good morning. Welcome to Scotts Miracle-Gro's Fiscal '24 Year-End Earnings Webcast.

The Scotts Miracle-Gro Company (SMG) Q4 2024 Earnings Call Transcript

While the top- and bottom-line numbers for Scotts (SMG) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Scotts (SMG) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Scotts Miracle-Gro (SMG) came out with a quarterly loss of $2.31 per share versus the Zacks Consensus Estimate of a loss of $1.94. This compares to loss of $2.77 per share a year ago.

Scotts Miracle-Gro (SMG) Reports Q4 Loss, Tops Revenue Estimates

Get a deeper insight into the potential performance of Scotts (SMG) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Gear Up for Scotts (SMG) Q4 Earnings: Wall Street Estimates for Key Metrics

MARYSVILLE, Ohio, Nov. 05, 2024 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), the world's leading marketer of branded consumer lawn and garden as well as indoor and hydroponic growing products, today announced that Rob Candelino has been named to its Board of Directors.

ScottsMiracle-Gro Appoints Rob Candelino to Board of Directors

MARYSVILLE, Ohio, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), the world's largest marketer of branded consumer lawn and garden as well as a leader in indoor and hydroponic growing products, announced that its Board of Directors has approved the payment of a cash dividend of $0.66 per share. The dividend is payable on Friday, December 6, 2024, to shareholders of record as of Friday, November 22, 2024.

The Scotts Miracle-Gro Company Announces Quarterly Dividend Payment

More cannabis companies are preparing to report earnings, and this could be big for the sector. There has been an increase in people investing in marijuana stocks. The reason is that it is the easiest way to be part of the industry without all the heavy lifting. You do not need to start a company and go into production. The ability for cannabis companies to be publicly traded gives people the opportunity to find top marijuana stocks to buy. The amount of growth and progress that occurred over the last several years is only proving why legal cannabis should have been established long ago.

These 3 Marijuana Stocks Could Hit Big Momentum

Curaleaf Holdings, Inc.

Trulieve Cannabis Corp.

The US cannabis industry is projected to grow significantly, with estimates suggesting it could reach $45.9 billion by 2025. This increase comes as more states legalize cannabis for both medical and recreational use. In recent weeks, news surrounding federal cannabis legalization has sparked renewed interest in marijuana stocks. Recent headlines include a push for reclassifying cannabis from a Schedule I drug, which would open doors for broader legalization. This development has provided momentum for many cannabis companies, causing their stocks to rise. As the industry evolves, it presents a wealth of opportunities for investors.

Top Performing Marijuana Stocks with Upward Momentum in the Last Month

The US cannabis industry is rapidly expanding, with sales projected to reach $45.8 billion by 2025. Ancillary cannabis companies, which provide essential products and services to the industry, are crucial to this growth. These companies support everything from cultivation to packaging, helping marijuana businesses thrive. Recently, headlines have been buzzing about potential federal legalization, as several bills have been introduced in Congress. If passed, these could accelerate industry expansion and lead to even greater investment opportunities. With the market's future looking bright, it's essential to keep an eye on key ancillary stocks this week.

Top Ancillary Cannabis Companies to Watch in October 2024

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here's Why Scotts Miracle-Gro (SMG) is a Strong Momentum Stock

SAN DIEGO , Sept. 30, 2024 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that a lawsuit was filed by a NYSE: SMG investor against certain directors of Scotts Miracle-Gro Company.

NYSE: SMG Lawsuit against Directors filed - Investors in shares of The Scotts Miracle-Gro Company (NYSE: SMG) should contact the Shareholders Foundation

The US cannabis industry is growing at a rapid pace, with sales expected to reach $52 billion by 2026. As more states move toward legalization, ancillary companies that provide essential products and services are also gaining traction. These companies, which do not directly handle cannabis but support its production, are vital to the industry's expansion. Recently, headlines have focused on discussions around federal legalization, sparking optimism for future growth. Investors looking to capitalize on this momentum should watch ancillary cannabis stocks, which often experience less regulatory risk than direct cannabis producers.

Best Ancillary Cannabis Stocks Poised for Growth Before Q4 2024

The strong recovery since their decline between 2021-2022, especially in the US consumer segment, is driving overall revenue growth despite challenges in the Hawthorne division. I'm encouraged by management's effective debt reduction efforts, which decreased borrowings by $600 million over the past year. Despite a 28% revenue decline in the Hawthorne segment, I find the segment's return to profitability and improving fundamentals quite promising.

Scotts Miracle-Gro: A Turnaround Is Very Probable

The Scotts Miracle-Gro Company's manufacturing facility in Fort Madison, Iowa, recently celebrated a Total Recordable Incident Rate of zero for 365 days.

ScottsMiracle-Gro's Fort Madison Plant Celebrates 365 Day Safety Record

The US cannabis industry has grown significantly, with projections estimating the market could reach $40 billion by 2025. As more states legalize cannabis, ancillary companies supporting the industry have become critical players. These companies provide essential products and services, such as hydroponic equipment and cultivation supplies. Recent headlines highlight the push for federal legalization as Congress considers new bills aimed at decriminalizing cannabis. Investors are closely watching this space as legalization could open new revenue streams. Given this promising outlook, ancillary cannabis stocks have become attractive for those seeking to capitalize on the industry's growth.

Best Ancillary Cannabis Stocks to Keep an Eye on This September

NEW YORK , Sept. 6, 2024 /PRNewswire/ -- Moore Law, PLLC, a shareholder law firm located on Wall Street, is investigating potential claims against: The Scotts Miracle-Gro Company (NYSE: SMG) **Shareholders should email Fletcher@fmoorelaw.com The investigation concerns misrepresentations or omissions regarding Scotts' debt covenants.

INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in The Scotts Miracle-Gro Company to Contact Law Firm

Marijuana stocks are caught once again in a downward trend due to more industry hold-ups. In recent news, the DEA who not long ago was on board and on track to reschedule cannabis has now put that action on pause. What a surprise! This is not an unfamiliar occurrence for the cannabis industry, especially during an election year. During this time candidates are focused on winning votes and meeting the needs of those voters.

3 Top Marijuana Stocks Anyalst Feel Are Good Investments

NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against The Scotts Miracle-Gro Company (NYSE: SMG) on behalf of long-term stockholders following a class action complaint that was filed against Scotts on June 6, 2024 with a Class Period from June 2, 2021 to August 1, 2023. Our investigation concerns whether the board of directors of Scotts have breached their fiduciary duties to the company.

SCOTTS ALERT: Bragar Eagel & Squire, P.C. is Investigating The Scotts Miracle-Gro Company on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Why Scotts Miracle-Gro (SMG) is a Top Momentum Stock for the Long-Term

Leafly Holdings

WM Technology

What will the future of marijuana stock investing and trading look like with better laws in place? Historically when there's been positive news on any federal or state-level reform most pot stocks saw better trading. Much of what takes place in the publicly traded side of the industry is based on speculation and leveraging volatility. As more people see the upside to cannabis overall the idea is it will lessen the inconsistent trading patterns.

The Best Marijuana Stocks To Watch For Big Gains In 2024

LOS ANGELES, CA / ACCESSWIRE / August 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Scotts Miracle-Gro Company ("Scotts" or "the Company") (NYSE:SMG) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

News for Scotts Miracle-Gro Stock (SMG)